Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Pathophysiology and etiology of edema in adults

INTRODUCTION

Edema is defined as a palpable swelling produced by expansion of the interstitial fluid volume. A variety of clinical conditions are associated with the development of edema, including heart failure, cirrhosis, and the nephrotic syndrome (table 1).

Some patients have localized edema. This can be caused by a variety of conditions, including venous obstruction, as occurs with deep vein thrombosis or venous stasis, and allergic reactions (such as laryngeal edema).

This topic will review the pathophysiology and etiology of generalized edematous states. The clinical manifestations, diagnosis, and therapy of edema are discussed separately. (See "Clinical manifestations and diagnosis of edema in adults" and "General principles of the treatment of edema in adults" and "Treatment of refractory edema in adults".)

PATHOPHYSIOLOGY OF EDEMA FORMATION

There are two basic steps involved in edema formation:

  • An alteration in capillary hemodynamics that favors the movement of fluid from the vascular space into the interstitium.
  • The retention of dietary or intravenously administered sodium and water by the kidneys.

                

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2014. | This topic last updated: Jan 29, 2013.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Guyton AC. Chapter 16. In: Textbook of Medical Physiology, 8th ed, Saunders, Philadelphia 1991.
  2. Taylor AE. Capillary fluid filtration. Starling forces and lymph flow. Circ Res 1981; 49:557.
  3. Renkin EM. B. W. Zweifach Award lecture. Regulation of the microcirculation. Microvasc Res 1985; 30:251.
  4. Crandall ED, Staub NC, Goldberg HS, Effros RM. Recent developments in pulmonary edema. Ann Intern Med 1983; 99:808.
  5. Deitch EA. The management of burns. N Engl J Med 1990; 323:1249.
  6. Belldegrun A, Webb DE, Austin HA 3rd, et al. Effects of interleukin-2 on renal function in patients receiving immunotherapy for advanced cancer. Ann Intern Med 1987; 106:817.
  7. Baumgartner I, Rauh G, Pieczek A, et al. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann Intern Med 2000; 132:880.
  8. Amoura Z, Papo T, Ninet J, et al. Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment. Am J Med 1997; 103:514.
  9. Cicardi M, Gardinali M, Bisiani G, et al. The systemic capillary leak syndrome: appearance of interleukin-2-receptor-positive cells during attacks. Ann Intern Med 1990; 113:475.
  10. Droder RM, Kyle RA, Greipp PR. Control of systemic capillary leak syndrome with aminophylline and terbutaline. Am J Med 1992; 92:523.
  11. Tahirkheli NK, Greipp PR. Treatment of the systemic capillary leak syndrome with terbutaline and theophylline. A case series. Ann Intern Med 1999; 130:905.
  12. Ohlsson K, Björk P, Bergenfeldt M, et al. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990; 348:550.
  13. Colletti LM, Remick DG, Burtch GD, et al. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990; 85:1936.
  14. Bollinger A, Frey J, Jäger K, et al. Patterns of diffusion through skin capillaries in patients with long-term diabetes. N Engl J Med 1982; 307:1305.
  15. Hommel E, Mathiesen ER, Aukland K, Parving HH. Pathophysiological aspects of edema formation in diabetic nephropathy. Kidney Int 1990; 38:1187.
  16. Brownlee M. Lilly Lecture 1993. Glycation and diabetic complications. Diabetes 1994; 43:836.
  17. Mayatepek E, Becker K, Gana L, et al. Leukotrienes in the pathophysiology of kwashiorkor. Lancet 1993; 342:958.
  18. Morgan AG, Terry SI. Impaired peritoneal fluid drainage in nephrogenic ascites. Clin Nephrol 1981; 15:61.
  19. Hammond TC, Takiyyuddin MA. Nephrogenic ascites: a poorly understood syndrome. J Am Soc Nephrol 1994; 5:1173.
  20. Parving HH, Hansen JM, Nielsen SL, et al. Mechanisms of edema formation in myxedema--increased protein extravasation and relatively slow lymphatic drainage. N Engl J Med 1979; 301:460.
  21. HOLLANDER W, REILLY P, BURROWS BA. Lymphatic flow in human subjects as indicated by the disappearance of 1-131-labeled albumin from the subcutaneous tissue. J Clin Invest 1961; 40:222.
  22. Taylor AE. The lymphatic edema safety factor: the role of edema dependent lymphatic factors (EDLF). Lymphology 1990; 23:111.
  23. Bräutigam P, Vanscheidt W, Földi E, et al. [Involvement of the lymphatic system in primary non-lymphogenic edema of the leg. Studies with 2-compartment lymphoscintigraphy]. Hautarzt 1997; 48:556.
  24. Szidon JP. Pathophysiology of the congested lung. Cardiol Clin 1989; 7:39.
  25. Kwan T, Pintea M, Garcia Morino F, et al. Transcapillary oncotic pressure in the edema of congestive heart failure. Nephron 1990; 54:21.
  26. Fauchald P. Transcapillary colloid osmotic gradient and body fluid volumes in renal failure. Kidney Int 1986; 29:895.
  27. Koomans HA, Kortlandt W, Geers AB, Dorhout Mees EJ. Lowered protein content of tissue fluid in patients with the nephrotic syndrome: observations during disease and recovery. Nephron 1985; 40:391.
  28. Zarins CK, Rice CL, Peters RM, Virgilio RW. Lymph and pulmonary response to isobaric reduction in plasma oncotic pressure in baboons. Circ Res 1978; 43:925.
  29. Schrier RW. Body fluid volume regulation in health and disease: a unifying hypothesis. Ann Intern Med 1990; 113:155.
  30. Schrier RW. An odyssey into the milieu intérieur: pondering the enigmas. J Am Soc Nephrol 1992; 2:1549.
  31. EPSTEIN FH, FERGUSON TB. The effect of the formation of an arteriovenous fistula upon blood volume. J Clin Invest 1955; 34:434.
  32. KOWALSKI HJ, ABELMANN WH. The cardiac output at rest in Laennec's cirrhosis. J Clin Invest 1953; 32:1025.
  33. Pérez-Ayuso RM, Arroyo V, Camps J, et al. Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis. Kidney Int 1984; 26:72.
  34. Henriksen JH, Bendtsen F, Gerbes AL, et al. Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta-adrenergic blockade and atrial natriuretic factor. Hepatology 1992; 16:1163.
  35. Fernandez-Seara J, Prieto J, Quiroga J, et al. Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology 1989; 97:1304.
  36. Cohn JN. Blood pressure and cardiac performance. Am J Med 1973; 55:351.
  37. Watkins L Jr, Burton JA, Haber E, et al. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. J Clin Invest 1976; 57:1606.
  38. Dzau VJ, Colucci WS, Hollenberg NK, Williams GH. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 1981; 63:645.
  39. Chonko AM, Bay WH, Stein JH, Ferris TF. The role of renin and aldosterone in the salt retention of edema. Am J Med 1977; 63:881.
  40. Rose BD, Post TW. Chapter 16. In: Clinical Physiology of Acid-Base and Electrolyte Disorders, McGraw-Hill, New York 2001.
  41. Blankfield RP, Finkelhor RS, Alexander JJ, et al. Etiology and diagnosis of bilateral leg edema in primary care. Am J Med 1998; 105:192.
  42. McHugh TJ, Forrester JS, Adler L, et al. Pulmonary vascular congestion in acute myocardial infarction: hemodynamic and radiologic correlations. Ann Intern Med 1972; 76:29.
  43. Warren JV, Stead EA. Fluid dynamics in chronic congestive heart failure: An interpretation of the mechanisms producing the edema, increased plasma volume, and elevated venous pressure in certain patients with prolonged congestive failure. Arch Intern Med 1944; 73:138.
  44. Dzau VJ. Renal and circulatory mechanisms in congestive heart failure. Kidney Int 1987; 31:1402.
  45. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 1988; 77:721.
  46. BRAUNWALD E, PLAUTH WH Jr, MORROW AG. A METHOD FOR THE DETECTION AND QUANTIFICATION OF IMPAIRED SODIUM EXCRETION. RESULTS OF AN ORAL SODIUM TOLERANCE TEST IN NORMAL SUBJECTS AND IN PATIENTS WITH HEART DISEASE. Circulation 1965; 32:223.
  47. Winaver J, Hoffman A, Burnett JC Jr, Haramati A. Hormonal determinants of sodium excretion in rats with experimental high-output heart failure. Am J Physiol 1988; 254:R776.
  48. Reddy HK, Weber KT, Janicki JS, McElroy PA. Hemodynamic, ventilatory and metabolic effects of light isometric exercise in patients with chronic heart failure. J Am Coll Cardiol 1988; 12:353.
  49. Higgins CB, Vatner SF, Franklin D, Braunwald E. Effects of experimentally produced heart failure on the peripheral vascular response to severe exercise in conscious dogs. Circ Res 1972; 31:186.
  50. Millard RW, Higgins CB, Franklin D, Vatner SF. Regulation of the renal circulation during severe exercise in normal dogs and dogs with experimental heart failure. Circ Res 1972; 31:881.
  51. Schwinger RH, Böhm M, Koch A, et al. The failing human heart is unable to use the Frank-Starling mechanism. Circ Res 1994; 74:959.
  52. Gault JH, Covell JW, Braunwald E, Ross J Jr. Left ventricular performance following correction of free aortic regurgitation. Circulation 1970; 42:773.
  53. Komamura K, Shannon RP, Ihara T, et al. Exhaustion of Frank-Starling mechanism in conscious dogs with heart failure. Am J Physiol 1993; 265:H1119.
  54. Markham RV Jr, Gilmore A, Pettinger WA, et al. Central and regional hemodynamic effects and neurohumoral consequences of minoxidil in severe congestive heart failure and comparison to hydralazine and nitroprusside. Am J Cardiol 1983; 52:774.
  55. Diazoxide therapy: use and risks. Ann Intern Med 1976; 85:529.
  56. Pohl JE, Thurston H, Swales JD. The dntidiuretic action of diazoxide. Clin Sci 1972; 42:145.
  57. Pettinger WA, Keeton K. Altered renin release and propranolol potentiation of vasodilatory drug hypotension. J Clin Invest 1975; 55:236.
  58. Russell RP. Side effects of calcium channel blockers. Hypertension 1988; 11:II42.
  59. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1984; 310:563.
  60. Christy NP, Shaver JC. Estrogens and the kidney. Kidney Int 1974; 6:366.
  61. PREEDY JR, AITKEN EH. The effect of estrogen on water and electrolyte metabolism. II. Hepatic disease. J Clin Invest 1956; 35:430.
  62. Tan EK, Ondo W. Clinical characteristics of pramipexole-induced peripheral edema. Arch Neurol 2000; 57:729.
  63. Hudis CA, Seidman AD, Crown JP, et al. Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer. J Clin Oncol 1996; 14:58.
  64. Trudeau ME, Eisenhauer EA, Higgins BP, et al. Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group. J Clin Oncol 1996; 14:422.
  65. Piccart MJ, Klijn J, Paridaens R, et al. Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer. J Clin Oncol 1997; 15:3149.
  66. Veverbrants E, Arky RA. Effects of fasting and refeeding. I. Studies on sodium, potassium and water excretion on a constant electrolyte and fluid intake. J Clin Endocrinol Metab 1969; 29:55.
  67. Saudek CD, Boulter PR, Knopp RH, Arky RA. Sodium retention accompanying insulin treatment of diabetes mellitus. Diabetes 1974; 23:240.
  68. Hopkins DF, Cotton SJ, Williams G. Effective treatment of insulin-induced edema using ephedrine. Diabetes Care 1993; 16:1026.
  69. DeFronzo RA, Cooke CR, Andres R, et al. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975; 55:845.
  70. Baum M. Insulin stimulates volume absorption in the rabbit proximal convoluted tubule. J Clin Invest 1987; 79:1104.
  71. Nakamura R, Emmanouel DS, Katz AI. Insulin binding sites in various segments of the rabbit nephron. J Clin Invest 1983; 72:388.